112 related articles for article (PubMed ID: 8175970)
41. [The expression and significance of chromogranin A and synaptophysin in adrenal gland tumors].
Feng C; Li HZ; Yan WG; Luo YF; Cao JL
Zhonghua Zhong Liu Za Zhi; 2005 Aug; 27(8):486-8. PubMed ID: 16188147
[TBL] [Abstract][Full Text] [Related]
42. Prospective study of the value of serum chromogranin A or serum gastrin levels in the assessment of the presence, extent, or growth of gastrinomas.
Goebel SU; Serrano J; Yu F; Gibril F; Venzon DJ; Jensen RT
Cancer; 1999 Apr; 85(7):1470-83. PubMed ID: 10193936
[TBL] [Abstract][Full Text] [Related]
43. [Estimation of clonidine test in differential diagnosis of pheochromocytoma from essential hypertension].
Nesović M; Cirić J; Zarković M; Popović V; Micić D; Mićić J
Srp Arh Celok Lek; 1990; 118(3-4):117-20. PubMed ID: 17977398
[TBL] [Abstract][Full Text] [Related]
44. [Plasma methoxyamines assay: a practical advance for the diagnosis of pheochromocytoma].
Peyrin L; Cottet-Emard JM; Pagliari R; Cottet-Emard RM; Badet C; Mornex R
Pathol Biol (Paris); 1994 Nov; 42(9):847-54. PubMed ID: 7753594
[TBL] [Abstract][Full Text] [Related]
45. Addition of 3-methoxytyramine or chromogranin A to plasma free metanephrines as the initial test for pheochromocytoma and paraganglioma: Which is the best diagnostic strategy.
Liu L; Xie W; Song Z; Wang T; Li X; Gao Y; Li Y; Zhang J; Guo X
Clin Endocrinol (Oxf); 2022 Feb; 96(2):132-138. PubMed ID: 34486152
[TBL] [Abstract][Full Text] [Related]
46. [Rational diagnosis in primary and recurrent pheochromocytoma].
Hiller WF; Schuppert F; Mössinger E; Pichlmayr R
Langenbecks Arch Chir Suppl Kongressbd; 1997; 114():422-4. PubMed ID: 9574170
[TBL] [Abstract][Full Text] [Related]
47. [Usefulness of chromogranin A determination in the diagnosis of neuroendocrine neoplasia].
Militello C; Cannizzaro R; Pradella P; Volpin E; Spirch S; Buonadonna A; De Appollonia L; Rossi C; Sigon R; Cipresso S; Terranova O
Chir Ital; 1999; 51(1):45-51. PubMed ID: 10514916
[TBL] [Abstract][Full Text] [Related]
48. The predictive value of diagnostic tests for pheochromocytoma.
Peplinski GR; Norton JA
Surgery; 1994 Dec; 116(6):1101-9; discussion 1109-10. PubMed ID: 7985094
[TBL] [Abstract][Full Text] [Related]
49. Chromogranin 'A' in normal subjects, essential hypertensives and adrenalectomized patients.
Giampaolo B; Angelica M; Antonio S
Clin Endocrinol (Oxf); 2002 Jul; 57(1):41-50. PubMed ID: 12100068
[TBL] [Abstract][Full Text] [Related]
50. Chromogranin A as serum marker for neuroendocrine neoplasia: comparison with neuron-specific enolase and the alpha-subunit of glycoprotein hormones.
Nobels FR; Kwekkeboom DJ; Coopmans W; Schoenmakers CH; Lindemans J; De Herder WW; Krenning EP; Bouillon R; Lamberts SW
J Clin Endocrinol Metab; 1997 Aug; 82(8):2622-8. PubMed ID: 9253344
[TBL] [Abstract][Full Text] [Related]
51. Circulating EM66 is a highly sensitive marker for the diagnosis and follow-up of pheochromocytoma.
Guillemot J; Anouar Y; Montero-Hadjadje M; Grouzmann E; Grumolato L; Roshmaninho-Salgado J; Turquier V; Duparc C; Lefebvre H; Plouin PF; Klein M; Muresan M; Chow BK; Vaudry H; Yon L
Int J Cancer; 2006 Apr; 118(8):2003-12. PubMed ID: 16287097
[TBL] [Abstract][Full Text] [Related]
52. [Plasma catecholamines; values in normal subjects and its use the localization of pheochromocytoma].
Chávez Lara B; Ortega Campos C; Sánchez Torres G; Serrano PA
Arch Inst Cardiol Mex; 1977; 47(2):151-9. PubMed ID: 901051
[TBL] [Abstract][Full Text] [Related]
53. Benign and malignant pheochromocytoma: diagnosis, treatment, and follow-Up.
Kebebew E; Duh QY
Surg Oncol Clin N Am; 1998 Oct; 7(4):765-89. PubMed ID: 9735133
[TBL] [Abstract][Full Text] [Related]
54. [Personal experience in diagnosis and localization of pheochromocytoma].
Andjelković Z; Tavcar I
Srp Arh Celok Lek; 2002 Jul; 130 Suppl 2():14-9. PubMed ID: 12584992
[TBL] [Abstract][Full Text] [Related]
55. [Clinical significance of serum chromogranin A analysis in endocrine tests of the adrenal medulla and sympathetic nervous system].
Sato J; Yamada R
Nihon Rinsho; 1989 Dec; 48 Suppl():1161-4. PubMed ID: 2621838
[No Abstract] [Full Text] [Related]
56. Chromogranin A.
Landsberg L
N Engl J Med; 1984 Sep; 311(12):794-5. PubMed ID: 6472370
[No Abstract] [Full Text] [Related]
57. [Catecholamines and their derivatives in the study of pheochromocytoma].
Zoghbi F; Landault C; Salmon N; Legrand JC
Ann Med Interne (Paris); 1983; 134(3):230-2. PubMed ID: 6625416
[TBL] [Abstract][Full Text] [Related]
58. [Detection of patients with pheochromocytoma using a cybernetic analysis method of the signs and symptoms of the disease].
Balazovjech I; Mikulecky M; Zanou DF; Zvara V
Ann Urol (Paris); 1996; 30(1):7-13. PubMed ID: 8712762
[TBL] [Abstract][Full Text] [Related]
59. Characterization and plasma measurement of the WE-14 peptide in patients with pheochromocytoma.
Guillemot J; Guérin M; Thouënnon E; Montéro-Hadjadje M; Leprince J; Lefebvre H; Klein M; Muresan M; Anouar Y; Yon L
PLoS One; 2014; 9(2):e88698. PubMed ID: 24523932
[TBL] [Abstract][Full Text] [Related]
60. [Merits of the assay of plasma catecholamines in a glucagon test to diagnosis of pheochromocytoma (author's transl)].
Bernheim C; Jaillon P; Graisely B; Cloarec M; Debray J; Cheymol G
Nouv Presse Med; 1978 Feb; 7(7):553-5. PubMed ID: 643581
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
